1. Home
  2. EQC vs WVE Comparison

EQC vs WVE Comparison

Compare EQC & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EQC
  • WVE
  • Stock Information
  • Founded
  • EQC 1986
  • WVE 2012
  • Country
  • EQC United States
  • WVE Singapore
  • Employees
  • EQC N/A
  • WVE N/A
  • Industry
  • EQC Real Estate Investment Trusts
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • EQC Real Estate
  • WVE Health Care
  • Exchange
  • EQC Nasdaq
  • WVE Nasdaq
  • Market Cap
  • EQC 2.2B
  • WVE 1.8B
  • IPO Year
  • EQC 1986
  • WVE 2015
  • Fundamental
  • Price
  • EQC $1.74
  • WVE $11.13
  • Analyst Decision
  • EQC
  • WVE Strong Buy
  • Analyst Count
  • EQC 0
  • WVE 10
  • Target Price
  • EQC N/A
  • WVE $21.60
  • AVG Volume (30 Days)
  • EQC 899.5K
  • WVE 734.1K
  • Earning Date
  • EQC 02-27-2025
  • WVE 03-05-2025
  • Dividend Yield
  • EQC N/A
  • WVE N/A
  • EPS Growth
  • EQC N/A
  • WVE N/A
  • EPS
  • EQC 0.38
  • WVE N/A
  • Revenue
  • EQC $58,433,000.00
  • WVE $53,610,000.00
  • Revenue This Year
  • EQC N/A
  • WVE N/A
  • Revenue Next Year
  • EQC N/A
  • WVE $48.58
  • P/E Ratio
  • EQC $4.52
  • WVE N/A
  • Revenue Growth
  • EQC N/A
  • WVE N/A
  • 52 Week Low
  • EQC $1.40
  • WVE $4.01
  • 52 Week High
  • EQC $21.00
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • EQC 21.11
  • WVE 44.53
  • Support Level
  • EQC $1.71
  • WVE $10.79
  • Resistance Level
  • EQC $1.75
  • WVE $11.78
  • Average True Range (ATR)
  • EQC 0.04
  • WVE 0.69
  • MACD
  • EQC 0.17
  • WVE 0.05
  • Stochastic Oscillator
  • EQC 54.55
  • WVE 43.95

About EQC Equity Commonwealth of Beneficial Interest

Equity Commonwealth is a real estate investment trust engaged in the acquisition, ownership, and operation of office buildings located throughout the United States. The vast majority of the company's real estate portfolio comprises office assets. These properties are fairly evenly dispersed between many of America's urban markets, notably Washington, Austin, and Denver. Equity Commonwealth derives the vast majority of its income in the form of rental revenue from tenants occupying its offices.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: